The European ​Medicines ‌Agency's committee on ‌Friday recommended a change to ⁠extend ‌the use of ‍Eli Lilly's blockbuster ...
South Africa recently became the first country in Africa to formally approve one version of these drugs for weight loss, and access is slowly spreading across the continent.
GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.
Experts warn that nearly one in four pregnant women in India may be affected, highlighting the urgent need for early ...
A cardiologist's assertion that Ozempic is a \"cardiometabolic medicine\" rather than just a weight-loss trend has sparked ...
Curating evidence-based lifestyle recommendations is key to achieving ideal cardiometabolic health in patients with obesity, ...
Dec 12 (Reuters) - The European Medicines ‌Agency's ​committee on Friday ‌recommended extending the use of Eli Lilly's ...
The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism.
Merck Foundation Chairman & Chief Executive Officer (CEO) and the First Lady of Zimbabwe Celebrate 7 Years of Long-Term ...
While Ozempic offers proven benefits for blood sugar control, weight management, and cardiovascular protection, its arrival ...
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Dec. /CNW/ — USANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion in 2024 ...